
Sign up to save your podcasts
Or


Today’s guest is Najat Khan, Chief R&D Officer and Chief Commercial Officer at Recursion Pharmaceuticals.
Recursion is widely recognized as one of the most visible—and so far, most successful—companies to emerge from the tech-bio movement. Many consider it the current industry leader.
It has become an iconic name in the field of artificial intelligence for drug discovery.
TPM E44 highlights >
Episode 44 links:
By Genialis4.7
77 ratings
Today’s guest is Najat Khan, Chief R&D Officer and Chief Commercial Officer at Recursion Pharmaceuticals.
Recursion is widely recognized as one of the most visible—and so far, most successful—companies to emerge from the tech-bio movement. Many consider it the current industry leader.
It has become an iconic name in the field of artificial intelligence for drug discovery.
TPM E44 highlights >
Episode 44 links:

21,983 Listeners

229,070 Listeners

4,356 Listeners

112,751 Listeners

56,508 Listeners

10,272 Listeners

9,901 Listeners

5,472 Listeners

16,038 Listeners